Africa News Line Thursday, 04.25.2024, 4:17 AM
Welcome Guest | RSS
Site menu

Main » Entries archive
AMSTERDAM - Wednesday, February 13th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Regulatory News :

Gemalto (Euronext NL 0000400653 GTO), the world leader in digital security, announces that its Cinterion® M2M technology is powering the innovative TRiLOC™ GPS Personal Locator Device (PLD) used to locate people with Autism Spectrum Disorder (ASD), dementia and Alzheimer’s disease. The easy-to-wear wristwatch solution uses an ultra-slim Cinterion module to provide 24/7 global cellular communications and Global Positioning System (GPS) tracking. The TRiLOC device helps caregivers locate and safeguard people with special needs while minimizing the need for constant physical supervision. Worldwide there are more than 30 million individuals suffering from autism or Alzheimer’s disease and more than 60 million caregivers are looking for solutions to improve their independence and safety1.

Developed by iLOC Technologies, the TRiLOC PLD integrates Gemalto’s Cinterion PHS8 M2M m ... Read more »
Views: 266 | Added by: uaeonlinenews | Date: 02.13.2013

RT System 2 – RealTIME and CableFREE seismic data acquisition system – scalable to high channel count configurations

SUGAR LAND, Texas - Wednesday, February 13th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Wireless Seismic, Inc., the leading innovator of real-time and cable-less seismic data acquisition systems for the oil and gas industry, announced today the purchase of its RT System 2 seismic data acquisition system by Dawson Geophysical Company, a leading provider of onshore seismic data acquisition services in North America.

"We have been development testing this new radio-based 2D and 3D system over the past 18 months under a variety of field conditions,” stated Stephen Jumper, CEO of Dawson Geophysical. "During that time, we have seen continuous improvement in the effectiveness and usability of the product. We have recently deployed this system on several proprietary 3D projects for independent operators in the mid-continent region, and we have been pleased with it ... Read more »
Views: 272 | Added by: uaeonlinenews | Date: 02.13.2013

New CommSuite platform enables operators to capitalize on modern messaging channels and better compete with over-the-top apps

ALISO VIEJO, Calif. - Tuesday, February 12th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Smith Micro Software, Inc. (NASDAQ: SMSI), a leading provider of wireless and mobility solutions, today announced the availability of their CommSuite® solution, an advanced voice and video messaging platform for mobile operators. The platform is designed to help operators generate new revenue streams and revitalize legacy voicemail systems through integrated, rich media communications such as video and avatar messaging, live videocast, voice-to-text transcription, and social sharing of messages.

As voice and text-based communications evolve into rich media communications, the rapid growth of video messaging applications, such as Skype, Tango and QikVideo, is having a negative impact on mobile operators’ bottom lines. Global analyst firm Ovum estimates opera ... Read more »
Views: 306 | Added by: africa-live | Date: 02.13.2013

WASHINGTON - Tuesday, February 12th 2013 [BUSINESS WIRE/ ME NewsWire]

The AdvanFort Company, a world leader in providing comprehensive maritime security solutions for the commercial shipping industry, was officially approved last week by the Panama Maritime Authority (PMA) to conduct counter-piracy operations aboard vessels flying the Panama flag.

"We at AdvanFort are very pleased that the world’s largest flag state has vetted our company and approved our highly-trained operators to protect their ships from piracy attack,” said Captain William H. Watson, president of AdvanFort.

"I want to personally thank Alfonso Castillero, Panama’s General Director of the Merchant Marine, for the professional manner in which this approval was handled.”

To facilitate the process, Mr. Watson travelled to Panama to meet with Mr. Castillero and with Mrs. Nyxkhari Ardilla, of the PMA’s Maritime Ships Security Department.

The Resolution (Number 106-26-DGMM) is dated 4 Feb ... Read more »
Views: 311 | Added by: uaeonlinenews | Date: 02.12.2013

DALLAS - Tuesday, February 12th 2013 [ME NewsWire]

(BUSINESS WIRE)-- What began as a simple message from a Facebook fan has turned into an International olfactory phenomenon. "I love the smell of a fresh Pizza Hut pizza so much, I wish I could bottle it,” a customer posted in late 2012. The brand that lives to "Make it Great” answered the charge by working with a world renowned Aromachologist to develop the one and only Eau de Pizza Hut.

The new, highly exclusive scent is available for the first time globally, but will only be awarded to the biggest Pizza Hut fans on a limited country-by-country basis. More than ten global markets will begin awarding fans the delicious scent today, just in time for Valentine’s Day.

"The Eau de Pizza Hut is perhaps the most unique scent we’ve ever developed,” said Ashlee Firsten of Aromachology, a NY-based custom perfumery. "The cologne has a slightly sweet base scent of freshly rising dough, but finishes decidedly savory with hints ... Read more »
Views: 303 | Added by: uaeonlinenews | Date: 02.12.2013

ME Newswire / Business Wire

LONDON - Tuesday, February 12th 2013

Seventy-six percent of sustainability leaders have reported that they have information on Ernst & Young’s global sustainability consulting capabilities, representing the highest brand awareness of the nine global professional services firms in the Global sustainability leaders survey: brands, by the independent analyst firm Verdantix.

Ernst & Young scored the highest in terms of the sustainability leader's perception of which company has the strongest capabilities to advise on global sustainability strategy. Thirty-nine percent of respondents said that they have engaged, would engage or consider engaging with Ernst & Young to advise on their sustainability strategy.

Ernst & Young also has the largest stake in sustainability assurance engagements with 14% of respondents reporting that they have already engaged with the company, and an additional 6% reporting likely future engagem ... Read more »
Views: 317 | Added by: uaeonlinenews | Date: 02.12.2013

SAN FRANCISCO - Tuesday, February 12th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Dolby Laboratories, Inc. (NYSE:DLB) today announced that shareholders have elected Micheline Chau to the Dolby Board of Directors at the 2013 annual meeting of shareholders, held on February 5. Ms. Chau will also serve on Dolby’s Audit Committee.

Ms. Chau was formerly President, Chief Operating Officer, and Chief Financial Officer of Lucasfilm Ltd., and brings significant experience in the entertainment industry to Dolby. She joins existing board members Peter Gotcher (Chairman), Kevin Yeaman, David Dolby, Nicholas Donatiello Jr., N.W. (Bill) Jasper Jr., Sanford R. Robertson, Roger S. Siboni, and Avadis Tevanian Jr.

Ms. Chau currently sits on the Boards of Directors of several private and nonprofit entities, including the California HealthCare Foundation, where she serves as Vice Chairman. Ms. Chau sat on the Board of Directors of Red Hat, Inc., a provider of open-source software solutions, ... Read more »
Views: 313 | Added by: uaeonlinenews | Date: 02.12.2013

REVLIMID Granted Approval for Treatment of Patients with Relapsed or Refractory Multiple Myeloma in China

BOUDRY, Switzerland - Monday, February 11th 2013 [ME NewsWire]

REVLIMID Granted Priority Review as Treatment for Patients with Relapsed or Refractory Mantle Cell Lymphoma - U.S. FDA PDUFA Date Set for June 5, 2013

(BUSINESS WIRE)-- Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that REVLIMID® (lenalidomide) has been granted full approval, which includes an Import Drug License (IDL) by the China State Food and Drug Administration (SFDA) for use in combination with dexamethasone as a treatment for patients with relapsed or refractory multiple myeloma who have received at least one prior therapy.

The approval of REVLIMID is based upon the safety and efficacy results of multiple pivotal randomized phase III international clinical trials in patients with relapsed or refractory multiple myeloma. Results from ... Read more »
Views: 301 | Added by: africa-live | Date: 02.12.2013

VILLEJUIF, France - Monday, February 11th 2013 [ME NewsWire]

(BUSINESS WIRE)-- The Worldwide Innovative Network (WIN) in personalized cancer medicine Consortium is proud to announce that New York University Cancer Institute has joined as a member of the Consortium. This new partnership will ensure that NYU Cancer Institute play an active and vital role in WIN’s efforts to translate the most innovative approaches in personalized cancer medicine into patient care worldwide. NYU Cancer Institute is an NCI-designated Comprehensive Cancer Center for more than 33 years, a prestigious ranking conferred to select institutions characterized by scientific excellence, the capability to integrate a diversity of research approaches, and leadership in NCI-funded research efforts.

The WIN Consortium was created to spur collaboration between all stakeholders in personalized cancer medicine and to carry out cross-sector, worldwide clinical trials through the Consortium’s global network of ... Read more »
Views: 280 | Added by: uaeonlinenews | Date: 02.12.2013

SUMMIT, N.J. - Sunday, February 10th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Celgene Corporation (NASDAQ: CELG) today announced the U.S. Food and Drug Administration (FDA) has approved POMALYST® brand therapy (pomalidomide) for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.

Approval is based on response rate. Clinical benefit, such as improvement in survival or symptoms, has not been verified.

Supporting the approval were the results of MM-002, a phase II, randomized, open-label study evaluating pomalidomide (4 mg once daily on days 1-21 of each 28-day cycle) plus low-dose dexamethasone (40 mg per day given only on Days 1, 8, 15 and 22 of each 28-day cycle for patients 75 years or younger, or 20 mg per day given only on Days 1, 8, 15 and 22 of each 28-day cycle for patients greater than 75 years of a ... Read more »
Views: 305 | Added by: uaeonlinenews | Date: 02.10.2013

« 1 2 ... 2332 2333 2334 2335 2336 ... 2369 2370 »
Search

Entries archive

Calendar
«  April 2024  »
SuMoTuWeThFrSa
 123456
78910111213
14151617181920
21222324252627
282930